< Terug naar vorige pagina
Onderzoeker
Arnold Vulto
- Disciplines:Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen
Affiliaties
- Klinische Farmacologie en Farmacotherapie (Afdeling)
Lid
Vanaf1 okt 2017 → Heden
Projecten
1 - 1 of 1
- Beleid voor best-value biologische geneesmiddelen in België.Vanaf3 sep 2019 → 18 sep 2023Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 10 van 84
- A Belgian policy framework for best-value biological medicines(2023)
Auteurs: Yannick Vandenplas, Isabelle Huys, Steven Simoens, Arnold Vulto
- The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis(2023)
Auteurs: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends(2023)
Auteurs: Elif Car, Arnold Vulto, Isabelle Huys, Steven Simoens
- Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study(2023)
Auteurs: Patrick Verschueren, Arnold Vulto
- An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and Spain(2023)
Auteurs: Arnold Vulto, Isabelle Huys, Steven Simoens
- Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis(2022)
Auteurs: Teresa Barcina Lacosta, Arnold Vulto, Isabelle Huys, Steven Simoens
- IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy(2022)
Auteurs: Arnold Vulto
Pagina's: 109 - 130 - How to select a best-value biological medicine? A practical model to support hospital pharmacists(2022)
Auteurs: Liese Barbier, Yannick Vandenplas, Isabelle Huys, Arnold Vulto
Pagina's: 2001 - 2011 - Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study(2022)
Auteurs: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking(2022)
Auteurs: Liese Barbier, Steven Simoens, Paul Declerck, Arnold Vulto, Isabelle Huys